Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene - PubMed (original) (raw)
. 1998 Aug;111(2):218-21.
doi: 10.1046/j.1523-1747.1998.00287.x.
J T Lear, A H Heagerty, A G Smith, P E Hutchinson, J Osborne, B Bowers, P W Jones, E Davies, W E Ollier, W Thomson, L Yengi, J Bath, A A Fryer, R C Strange
Affiliations
- PMID: 9699720
- DOI: 10.1046/j.1523-1747.1998.00287.x
Free article
Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene
F Ichii-Jones et al. J Invest Dermatol. 1998 Aug.
Free article
Abstract
Allelic variation at the melanocyte stimulating hormone receptor (MC1R) gene has been linked with sun-sensitive skin types, suggesting it is a susceptibility candidate for melanoma. We determined the frequency of the val92met, asp294his, and asp84glu MC1R alleles in 190 Caucasian controls and 306 melanoma cases and studied their association with skin type and hair color. The percentage of controls with at least one val92met, asp294his, or asp84glu allele was 17.3%, 6.8%, and 3.5%, respectively. Individually, frequencies of the val92met, asp294his, or asp84glu alleles in the controls with skin types 3 and 4 were similar to those with skin types 1 and 2. Trend analysis, however, did identify an association (exact p = 0.048, two-sided test) between skin type and MC1R variants in the group comprising all controls with any one or more of these alleles. There was no association between MC1R alleles and hair color. Allele frequencies were not different in melanoma cases and controls. There were no associations between skin types and the proportion of cases with the asp294his or asp84glu alleles, though the association between skin type and the val92met allele approached significance (exact p = 0.09, two-sided test). Unexpectedly, in the group comprising all cases with one or more variant alleles, the proportion of subjects with variant alleles increased with skin types associated with tanning rather than burning, although trend analysis showed that this association did not quite reach statistical significance (exact p = 0.08, two-sided test). Asp84glu (but not val92met or asp294his) variant alleles were more common in subjects with blonde hair, although the relationship between the asp84glu allele and hair color did not achieve statistical significance (chi(2)3 = 6.16, exact p = 0.10). We interpret the data presented as indicating that polymorphism at MC1R does not appear a major determinant of skin type, at least in terms of these allelic variants. Furthermore, considered alone, these alleles are not susceptibility candidates for malignant melanoma.
Comment in
- Skin type, melanoma, and melanocortin 1 receptor variants.
Healy E, Todd C, Jackson IJ, Birch-Machin M, Rees JL. Healy E, et al. J Invest Dermatol. 1999 Apr;112(4):512-3. doi: 10.1046/j.1523-1747.1999.00554.x. J Invest Dermatol. 1999. PMID: 10201538 No abstract available.
Similar articles
- Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma.
Strange RC, Ellison T, Ichii-Jones F, Bath J, Hoban P, Lear JT, Smith AG, Hutchinson PE, Osborne J, Bowers B, Jones PW, Fryer AA. Strange RC, et al. Pharmacogenetics. 1999 Jun;9(3):269-76. Pharmacogenetics. 1999. PMID: 10471058 - Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.
Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN. Kennedy C, et al. J Invest Dermatol. 2001 Aug;117(2):294-300. doi: 10.1046/j.0022-202x.2001.01421.x. J Invest Dermatol. 2001. PMID: 11511307 - The melanocyte stimulating hormone receptor polymorphism: association of the V92M and A294H alleles with basal cell carcinoma.
Jones FI, Ramachandran S, Lear J, Smith A, Bowers B, Ollier WE, Jones P, Fryer AA, Strange RC. Jones FI, et al. Clin Chim Acta. 1999 Apr;282(1-2):125-34. doi: 10.1016/s0009-8981(99)00017-0. Clin Chim Acta. 1999. PMID: 10340440 - The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes.
Sturm RA, Duffy DL, Box NF, Chen W, Smit DJ, Brown DL, Stow JL, Leonard JH, Martin NG. Sturm RA, et al. Pigment Cell Res. 2003 Jun;16(3):266-72. doi: 10.1034/j.1600-0749.2003.00041.x. Pigment Cell Res. 2003. PMID: 12753400 Review. - The melanocortin-1 receptor gene polymorphism and association with human skin cancer.
Beaumont KA, Liu YY, Sturm RA. Beaumont KA, et al. Prog Mol Biol Transl Sci. 2009;88:85-153. doi: 10.1016/S1877-1173(09)88004-6. Epub 2009 Oct 7. Prog Mol Biol Transl Sci. 2009. PMID: 20374726 Review.
Cited by
- Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma.
Ferrucci LM, Cartmel B, Molinaro AM, Gordon PB, Leffell DJ, Bale AE, Mayne ST. Ferrucci LM, et al. J Invest Dermatol. 2012 Apr;132(4):1272-9. doi: 10.1038/jid.2011.402. Epub 2011 Dec 8. J Invest Dermatol. 2012. PMID: 22158557 Free PMC article. - MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.
García-Borrón JC, Abdel-Malek Z, Jiménez-Cervantes C. García-Borrón JC, et al. Pigment Cell Melanoma Res. 2014 Sep;27(5):699-720. doi: 10.1111/pcmr.12257. Epub 2014 May 30. Pigment Cell Melanoma Res. 2014. PMID: 24807163 Free PMC article. Review. - Inherited variation at MC1R and histological characteristics of primary melanoma.
Taylor NJ, Busam KJ, From L, Groben PA, Anton-Culver H, Cust AE, Begg CB, Dwyer T, Gallagher RP, Gruber SB, Orlow I, Rosso S, Thomas NE, Zanetti R, Rebbeck TR, Berwick M, Kanetsky PA. Taylor NJ, et al. PLoS One. 2015 Mar 19;10(3):e0119920. doi: 10.1371/journal.pone.0119920. eCollection 2015. PLoS One. 2015. PMID: 25790105 Free PMC article. - Is obesity a risk factor for melanoma?
Arbel Y, Arbel Y, Kerner A, Kerner M. Arbel Y, et al. BMC Cancer. 2023 Feb 22;23(1):178. doi: 10.1186/s12885-023-10560-8. BMC Cancer. 2023. PMID: 36814240 Free PMC article. - Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells.
Eves P, Haycock J, Layton C, Wagner M, Kemp H, Szabo M, Morandini R, Ghanem G, García-Borrón JC, Jiménez-Cervantes C, Mac Neil S. Eves P, et al. Br J Cancer. 2003 Nov 17;89(10):2004-15. doi: 10.1038/sj.bjc.6601349. Br J Cancer. 2003. PMID: 14612916 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical